Cargando…

Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis

Detalles Bibliográficos
Autores principales: Pardanani, A, Abdelrahman, R A, Finke, C, Lasho, T T, Begna, K H, Al-Kali, A, Hogan, W J, Litzow, M R, Hanson, C A, Ketterling, R P, Tefferi, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360208/
https://www.ncbi.nlm.nih.gov/pubmed/25322686
http://dx.doi.org/10.1038/leu.2014.306
_version_ 1782361513840869376
author Pardanani, A
Abdelrahman, R A
Finke, C
Lasho, T T
Begna, K H
Al-Kali, A
Hogan, W J
Litzow, M R
Hanson, C A
Ketterling, R P
Tefferi, A
author_facet Pardanani, A
Abdelrahman, R A
Finke, C
Lasho, T T
Begna, K H
Al-Kali, A
Hogan, W J
Litzow, M R
Hanson, C A
Ketterling, R P
Tefferi, A
author_sort Pardanani, A
collection PubMed
description
format Online
Article
Text
id pubmed-4360208
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-43602082015-03-17 Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis Pardanani, A Abdelrahman, R A Finke, C Lasho, T T Begna, K H Al-Kali, A Hogan, W J Litzow, M R Hanson, C A Ketterling, R P Tefferi, A Leukemia Letter to the Editor Nature Publishing Group 2015-03 2014-11-11 /pmc/articles/PMC4360208/ /pubmed/25322686 http://dx.doi.org/10.1038/leu.2014.306 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Letter to the Editor
Pardanani, A
Abdelrahman, R A
Finke, C
Lasho, T T
Begna, K H
Al-Kali, A
Hogan, W J
Litzow, M R
Hanson, C A
Ketterling, R P
Tefferi, A
Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis
title Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis
title_full Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis
title_fullStr Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis
title_full_unstemmed Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis
title_short Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis
title_sort genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360208/
https://www.ncbi.nlm.nih.gov/pubmed/25322686
http://dx.doi.org/10.1038/leu.2014.306
work_keys_str_mv AT pardanania geneticdeterminantsofresponseandsurvivalinmomelotinibtreatedpatientswithmyelofibrosis
AT abdelrahmanra geneticdeterminantsofresponseandsurvivalinmomelotinibtreatedpatientswithmyelofibrosis
AT finkec geneticdeterminantsofresponseandsurvivalinmomelotinibtreatedpatientswithmyelofibrosis
AT lashott geneticdeterminantsofresponseandsurvivalinmomelotinibtreatedpatientswithmyelofibrosis
AT begnakh geneticdeterminantsofresponseandsurvivalinmomelotinibtreatedpatientswithmyelofibrosis
AT alkalia geneticdeterminantsofresponseandsurvivalinmomelotinibtreatedpatientswithmyelofibrosis
AT hoganwj geneticdeterminantsofresponseandsurvivalinmomelotinibtreatedpatientswithmyelofibrosis
AT litzowmr geneticdeterminantsofresponseandsurvivalinmomelotinibtreatedpatientswithmyelofibrosis
AT hansonca geneticdeterminantsofresponseandsurvivalinmomelotinibtreatedpatientswithmyelofibrosis
AT ketterlingrp geneticdeterminantsofresponseandsurvivalinmomelotinibtreatedpatientswithmyelofibrosis
AT tefferia geneticdeterminantsofresponseandsurvivalinmomelotinibtreatedpatientswithmyelofibrosis